Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis
- PMID: 3572934
Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis
Abstract
Outcomes were compared between consecutive patients who had received either total lymphoid irradiation (TLI) or immunosuppressant treatment for intractable rheumatoid arthritis (RA). There were 33 TLI and 32 immunosuppressive recipients; all patients had failed standard therapy. Average followup from the start of therapy was 2.7 years for TLI and 5.9 years for immunosuppressive recipients. Final disability levels were the same in both groups; mortality was equal in both groups as well. There were more hospitalizations for infections in the TLI group and the infecting organisms tended to be staphylococcus or gram negative organisms. Apart from infections, there were more adverse effects reported in the immunosuppressive therapy group.
Similar articles
-
Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.J Heart Lung Transplant. 1997 Feb;16(2):179-89. J Heart Lung Transplant. 1997. PMID: 9059929
-
The clinical use of immunosuppressive drugs.Med J Aust. 1973 Apr 14;1(15):749-52. Med J Aust. 1973. PMID: 4707372 No abstract available.
-
Treatment of rheumatoid arthritis with total lymphoid irradiation: long-term survival.Arthritis Rheum. 2001 Jul;44(7):1525-8. doi: 10.1002/1529-0131(200107)44:7<1525::AID-ART274>3.0.CO;2-3. Arthritis Rheum. 2001. PMID: 11465702 Clinical Trial.
-
[Treatment of chronic diseases of connective tissue by cytostatic drugs].Rev Clin Esp. 1970 Mar;116(6):539-48. Rev Clin Esp. 1970. PMID: 4996836 Review. Spanish. No abstract available.
-
[Cytostatic drugs in the treatment of rheumatic and connective tissue diseases].Duodecim. 1998;114(3):243-51. Duodecim. 1998. PMID: 10895494 Review. Finnish. No abstract available.
Cited by
-
Rheumatoid arthritis in the aged. Incidence and optimal management.Drugs Aging. 1993 Nov-Dec;3(6):487-501. doi: 10.2165/00002512-199303060-00003. Drugs Aging. 1993. PMID: 8312674 Review.
-
New perspectives of secondary and tertiary therapy for rheumatoid arthritis.Drugs. 1989 May;37(5):739-54. doi: 10.2165/00003495-198937050-00007. Drugs. 1989. PMID: 2663418 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical